Here are five key notes:
1. Eight analysts gave AmSurg a short term price target of $83.63.
2. AmSurg has a higher price target estimate of $95 and a lower price estimate of $54.
3. The shares closed down 0.31 percent on Mon., Sept. 14. The company is up 15.17 percent in the last three-month period.
4. The company has a 52-week high of $87.21 and a 52-week low of $47.68.
5. AmSurg has a market cap of $3.9 billion.
More articles on surgery centers:
HCA receives ‘B+’ credit rating — 4 notes
4 new joint venture ASCs — July & August 2015
Tenet shares fall 0.7% — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
